1. Beyond current aprepitant evidence: room for improvement on dose selection and chemotherapy-induced nausea and vomiting risk factors

   • Lucas Miyake Okumura

   Letter to the Editor 10 December 2015 Pages: 1009 - 1010

2. Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography

   • Seok-In Hong
   • Shin Ahn
   • Jae-Lyun Lee

   Original Article 04 August 2015 Pages: 1011 - 1017

   

3. Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases

   • Lei Zhang
   • Yan-Jun Su
   • Chang-Li Wang

   Original Article 06 August 2015 Pages: 1019 - 1024

4. Should clinicians always administer dexamethasone beyond 24 h after chemotherapy to control delayed nausea and vomiting caused by moderately emetogenic regimens? Insight from the re-evaluation of two randomized studies

   • Luigi Celio
   • Erminio Bonizzoni
   • Matti Aapro

   Original Article Open access 06 August 2015 Pages: 1025 - 1034

   

5. Low-level laser therapy prevents severe oral mucositis in patients submitted to hematopoietic stem cell transplantation: a randomized clinical trial

   • Betânia Ferreira
   • Fabiana Moura da Motta Silveira
   • Flávia Augusta de Orange

   Original Article 07 August 2015 Pages: 1035 - 1042

   

6. Evaluating the efficacy of a self-guided Web-based CBT intervention for reducing cancer-distress: a randomised controlled trial

   • Lisa Beatty
   • Bogda Koczwara
   • Tracey Wade

   Original Article 07 August 2015 Pages: 1043 - 1051

   

7. A new once-a-day fentanyl citrate patch (Fentos® Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch

   • Kazuhiko Koike
   • Takeshi Terui
   • Kunihiko Ishitani

   Original Article 07 August 2015 Pages: 1053 - 1059

   

8. Phase II evaluation of S-adenosyl-L-methionine (SAMe) for the treatment of hot flashes

   • Kunal C. Kadakia
   • Charles L. Loprinzi
   • Debra L. Barton

   Original Article 08 August 2015 Pages: 1061 - 1069

   

9. MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy

   • Collin Zimmerman
   • Pamela J. Atherton
   • Charles L. Loprinzi

   Original Article 08 August 2015 Pages: 1071 - 1078

   

10. Factors associated with aggressive end of life cancer care

    • Lesley A. Henson
    • Barbara Gomes
    • on behalf of BuildCARE

    Original Article Open access 08 August 2015 Pages: 1079 - 1089

    

11. Management of anemia and iron deficiency in a cancer center in France

    • Florence Laï-Tiong
    • Cloé Brami
    • Nicolas Jovenin

    Original Article 08 August 2015 Pages: 1091 - 1096

    

12. The effect of melatonin on sleep and quality of life in patients with advanced breast cancer

    • Pasquale F. Innominato
    • Andrew S. Lim
    • Georg A. Bjarnason

    Original Article 11 August 2015 Pages: 1097 - 1105

    

13. Understanding domains of health-related quality of life concerns of Singapore Chinese patients with advanced cancer: a qualitative analysis

    • GL Lee
    • GSY Pang
    • YB Cheung

    Original Article 13 August 2015 Pages: 1107 - 1118

14. Safety and tolerability of Kinesio^® Taping in patients with arm lymphedema: medical device clinical study

    • Jacqueline de Carvalho Martins
    • Suzana Sales Aguiar
    • Anke Bergmann

    Original Article 14 August 2015 Pages: 1119 - 1124

    

15. Sixty-minute infusion rituximab protocol allows for safe and efficient workflow

    • Emily Dotson
    • Brooke Crawford
    • Jeffrey Jones

    Original Article 14 August 2015 Pages: 1125 - 1129

    

16. How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study

    • Julie Vanbockstael
    • Elodie Coquan
    • Florence Joly

    Original Article 14 August 2015 Pages: 1131 - 1138

    

17. Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial

    • Kajal Gokal
    • Deborah Wallis
    • Fehmidah Munir

    Original Article 15 August 2015 Pages: 1139 - 1166

    

18. Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers

    • Jaime M. Preussler
    • Lih-Wen Mau
    • Ellen M. Denzen

    Original Article 15 August 2015 Pages: 1167 - 1174

    

19. Taxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective study

    • Tulay Kus
    • Gokmen Aktas
    • Celaletdin Camci

    Original Article 18 August 2015 Pages: 1175 - 1179

20. Venous access: the patient experience

    • Melissa Robinson-Reilly
    • Penny Paliadelis
    • Mary Cruickshank

    Original Article 18 August 2015 Pages: 1181 - 1187

21. Reversal of muscle atrophy by Zhimu and Huangbai herb pair via activation of IGF-1/Akt and autophagy signal in cancer cachexia

    • Pengwei Zhuang
    • Jinbao Zhang
    • Hongyan Li

    Original Article 18 August 2015 Pages: 1189 - 1198

    

22. Risk and management of venous thromboembolisms in bevacizumab-treated metastatic colorectal cancer patients

    • Irene Yu
    • Leo Chen
    • Winson Y. Cheung

    Original Article 19 August 2015 Pages: 1199 - 1208

23. Validating self-report and proxy reports of the Dexamethasone Symptom Questionnaire -Chronic for the evaluation of longer-term corticosteroid toxicity

    • Meera Agar
    • Eng-Siew Koh
    • On behalf of the Cooperative Trials Group for Neuro-Oncology (COGNO)

    Original Article 21 August 2015 Pages: 1209 - 1218

    

24. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up

    • Neil Majithia
    • Pamela J. Atherton
    • Stephanie L. Hines

    Original Article 23 August 2015 Pages: 1219 - 1226

    

25. Evaluation of a weekly speech pathology/dietetic service model for providing supportive care intervention to head and neck cancer patients and their carers during (chemo)radiotherapy

    • Laurelie R. Wall
    • Bena Cartmill
    • Sandro V. Porceddu

    Original Article 25 August 2015 Pages: 1227 - 1234

26. The cultural constructs of cancer-related fatigue among American Indian cancer survivors

    • Felicia Schanche Hodge
    • Tracy Line Itty
    • Angelina Pham

    Original Article 25 August 2015 Pages: 1235 - 1240

27. Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life

    • Lori Brotto
    • Michael Brundage
    • A Gynecologic Cancer Intergroup Study of the NCIC Clinical Trials Group (NCIC CTG), the European Organization for Research and Treatment of Cancer—Gynecologic Cancer Group (EORTC-GCG) and the Grupo de Investigación de Cáncer de Ovario (GEICO)

    Original Article 25 August 2015 Pages: 1241 - 1249

    

28. Presentation patterns and outcomes of patients with cancer accessing care in emergency departments in Victoria, Australia

    • Dania M. van der Meer
    • Tracey J. Weiland
    • Anne-Maree Kelly

    Original Article 26 August 2015 Pages: 1251 - 1260

29. An online self-care education program to support patients after total laryngectomy: feasibility and satisfaction

    • Ingrid C. Cnossen
    • Cornelia F. van Uden-Kraan
    • Irma M. Verdonck-de Leeuw

    Original Article Open access 26 August 2015 Pages: 1261 - 1268

    

30. Transition to the new role of caregiving for families of patients with breast cancer: a qualitative descriptive exploratory study

    • Masoumeh Hashemi-Ghasemabadi
    • Fariba Taleghani
    • Shahnaz Kohan

    Original Article 26 August 2015 Pages: 1269 - 1276

31. Sexual function, depression, and quality of life in patients with cervical cancer

    • Hyewoo Bae
    • Hyojung Park

    Original Article 26 August 2015 Pages: 1277 - 1283

32. Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial

    • Matteo Lambertini
    • Paolo Bruzzi
    • Lucia Del Mastro

    Original Article 27 August 2015 Pages: 1285 - 1294

    

33. Illness perceptions among cancer survivors

    • Na Zhang
    • Richard Fielding
    • Wendy Wing Tak Lam

    Original Article 28 August 2015 Pages: 1295 - 1304

34. Differences of symptoms in head and neck cancer patients with and without lymphedema

    • Jie Deng
    • Barbara A. Murphy
    • Sheila H. Ridner

    Original Article 29 August 2015 Pages: 1305 - 1316

35. Mechanisms that contribute to the tendency to continue chemotherapy in patients with advanced cancer. Qualitative observations in the clinical setting

    • Linda Brom
    • Bregje D. Onwuteaka-Philipsen
    • H Roeline W. Pasman

    Original Article Open access 02 September 2015 Pages: 1317 - 1325

    

36. Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases

    • Roger von Moos
    • Jean-Jacques Body
    • Yi Qian

    Original Article Open access 02 September 2015 Pages: 1327 - 1337

    

37. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study

    • Anita R. Peoples
    • Peter W. Bushunow
    • Gary R. Morrow

    Original Article 02 September 2015 Pages: 1339 - 1347

    

38. Fatigue and its associated psychosocial factors in cancer patients on active palliative treatment measured over time

    • Marlies E. W. J. Peters
    • Martine M. Goedendorp
    • Winette T. A. van der Graaf

    Original Article Open access 03 September 2015 Pages: 1349 - 1355

    

39. Effect of minimal enteral feeding on recovery in a methotrexate-induced gastrointestinal mucositis rat model

    • Nicoline S. S. Kuiken
    • Edmond H. H. M. Rings
    • Wim J. E Tissing

    Original Article Open access 03 September 2015 Pages: 1357 - 1364

    

40. Poor chemotherapy-induced nausea and vomiting control in children receiving intermediate or high dose methotrexate

    • Helen Vol
    • Jacqueline Flank
    • L. Lee Dupuis

    Original Article 03 September 2015 Pages: 1365 - 1371

    

41. Patients’ experiences and perspectives of multiple concurrent symptoms in advanced cancer: a semi-structured interview study

    • Skye T. Dong
    • Phyllis N. Butow
    • Melanie R. Lovell

    Original Article 04 September 2015 Pages: 1373 - 1386

    

42. Subtypes of depression in cancer patients: an empirically driven approach

    • Lei Zhu
    • Adelita V. Ranchor
    • Maya J. Schroevers

    Original Article Open access 05 September 2015 Pages: 1387 - 1396

    

43. Port catheter versus peripherally inserted central catheter for postoperative chemotherapy in early breast cancer: a retrospective analysis of 448 patients

    • L. Lefebvre
    • E. Noyon
    • F. Clatot

    Original Article 05 September 2015 Pages: 1397 - 1403

    

44. Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy

    • Yoshimasa Kosaka
    • Hirokazu Tanino
    • Masahiko Watanabe

    Original Article Open access 08 September 2015 Pages: 1405 - 1411

    

45. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?

    • Atilla Soran
    • Ebru Menekse
    • Ronald Johnson

    Original Article 09 September 2015 Pages: 1413 - 1419

    

46. Chemotherapy at end-of-life: an integration of oncology and palliative team

    • Wing-lok Chan
    • Ka-on Lam
    • Kwok-keung Yuen

    Review Article 25 November 2015 Pages: 1421 - 1427

47. Interventional options for the management of refractory cancer pain—what is the evidence?

    • Petra Vayne-Bossert
    • Banafsheh Afsharimani
    • Janet Hardy

    Review Article 11 December 2015 Pages: 1429 - 1438

48. National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons

    • Neil Majithia
    • Sarah M. Temkin
    • Charles L. Loprinzi

    Review Article 19 December 2015 Pages: 1439 - 1447